China Molybdenum announced that as of October 29, the company had repurchased 92.3991 million shares through centralized bidding, accounting for 0.43% of the company's current total share capital, with a maximum transaction price of 7.28 yuan per share and a minimum transaction price of 5.77 yuan per share. the total transaction amount is 641 million yuan (excluding transaction fees).

According to China Molybdenum's third quarterly report for 2021, the company's main income was 126.559 billion yuan, up 57.59% from the same period last year; the net profit from home was 3.558 billion yuan, up 121.07% from the same period last year; and the non-net profit was 1.914 billion yuan, up 153.95% from the same period last year. Among them, in the third quarter of 2021, the company's main income in a single quarter was 41.743 billion yuan, up 24.37% from the same period last year; and the net profit in a single quarter was 1.15 billion yuan, up 91.06% from the same period last year. The non-net profit in a single quarter was 513 million yuan, up 108.6% from the same period last year; the debt ratio was 65.92%, the investment income was 173 million yuan, the financial expenses were 919 million yuan, and the gross profit margin was 9.23%.

A total of nine institutions have rated the stock in the last 90 days, seven have bought ratings and two have increased their holdings; the average institutional target price has been 8.06 in the past 90 days; the net inflow of financing in the past three months has increased by 196 million, and the net outflow of securities has increased by 15.5363 million. The balance of securities lending decreased. According to the Securities Star valuation analysis tool, China Molybdenum (603993) has a good company rating of 3.5 stars, a good price rating of 2.5 stars, and a comprehensive valuation rating of 3 stars.

The chairman of the company is Yuan Honglin. Mr. Yuan Honglin: born in November 1967, Chinese nationality, no permanent residence abroad, master's degree, from August 1990 to May 2000, worked in Bank of China Ltd. Nantong Branch, served as Vice President of Rudong Branch, Branch Credit Management Manager; from June 2000 to August 2007, worked in China Merchants Bank Shanghai Branch, served as President of Jiangwan Branch and General Manager of Enterprise Banking Department From September 2007 to September 2012, he worked in Ping an Bank, served successively as assistant president and vice president of Shanghai Branch (responsible for overall business operation), general manager of corporate banking department, and in charge of business in North China. Since October 2012, he was appointed Deputy General Manager of Hongshang Capital Equity Investment Co., Ltd., and non-Executive Director of Luoyang Luanchuan Molybdenum Group Co., Ltd. Since November 2013. Since May 2017, he has been the chairman of Sino-French Life Insurance Co., Ltd.; since June 2020, he has been the chairman of Luoyang Luanchuan Molybdenum Group Co., Ltd.

This article is compiled by the Securities Star data Center according to the public data and does not constitute investment opinions or suggestions. If there are any questions in the article, please contact us.